Genpact (G) Shares Down 6.1% Following Analyst Downgrade
Genpact Limited (NYSE:G) shares dropped 6.1% during trading on Tuesday after JPMorgan Chase & Co. lowered their price target on the stock from $38.00 to $37.00. JPMorgan Chase & Co. currently has a neutral rating on the stock. Genpact traded as low as $30.16 and last traded at $30.32. Approximately 1,515,331 shares traded hands during mid-day trading, an increase of 77% from the average daily volume of 856,588 shares. The stock had previously closed at $32.30.
G has been the subject of several other research reports. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $36.00 price objective on shares of Genpact in a research note on Tuesday. BMO Capital Markets upped their price objective on Genpact to $35.00 and gave the company a “market perform” rating in a research note on Tuesday. Zacks Investment Research downgraded Genpact from a “buy” rating to a “hold” rating in a research note on Tuesday, January 9th. Citigroup lowered their price objective on Genpact from $39.00 to $37.50 and set a “buy” rating for the company in a research note on Tuesday. Finally, Robert W. Baird reaffirmed a “buy” rating and issued a $38.00 price objective on shares of Genpact in a research note on Friday, November 10th. Four investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Genpact has a consensus rating of “Buy” and a consensus price target of $34.65.
In other Genpact news, SVP Piyush Mehta sold 12,500 shares of the stock in a transaction that occurred on Monday, November 27th. The shares were sold at an average price of $32.00, for a total transaction of $400,000.00. Following the completion of the sale, the senior vice president now owns 77,944 shares of the company’s stock, valued at approximately $2,494,208. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Arvinder Singh sold 22,690 shares of the stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $33.95, for a total transaction of $770,325.50. The disclosure for this sale can be found here. Insiders have sold a total of 1,660,470 shares of company stock valued at $50,598,982 in the last three months. Insiders own 1.41% of the company’s stock.
The firm has a market cap of $6,235.27, a PE ratio of 23.01, a P/E/G ratio of 2.01 and a beta of 0.57. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.77.
Genpact (NYSE:G) last announced its quarterly earnings data on Monday, February 12th. The business services provider reported $0.43 EPS for the quarter, topping the consensus estimate of $0.41 by $0.02. The company had revenue of $734.41 million during the quarter, compared to the consensus estimate of $723.55 million. Genpact had a net margin of 9.61% and a return on equity of 23.53%. The company’s quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.43 EPS. sell-side analysts anticipate that Genpact Limited will post 1.61 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 21st. Stockholders of record on Friday, March 9th will be given a dividend of $0.075 per share. This is an increase from Genpact’s previous quarterly dividend of $0.06. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $0.30 annualized dividend and a dividend yield of 0.97%. Genpact’s dividend payout ratio (DPR) is 17.91%.
Genpact Company Profile
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.